Jeff Wolf

Great time-lapse of our Scorpion clean room pods being installed in our San Antonio facility. The pods are #MadeinAmerica, as is all of our Scorpion manufacturing. Looking forward to a ribbon-cutting of our first manufacturing facility in the coming months. We're getting there!

Excited to announce $HTBX acquisition of Elusys. Their post-exposure #Anthrax countermeasure, stockpiled by US Gov., is the only anthrax countermeasure with foreign approvals as well. Going all-in with Elusys & RapidVax countermeasures for biodefense. heatbio.com/news-media/new…

Great to step out from the $HTBX research lab to hang out with Nigel Walker from @thatsnicellc on The Road to 50 States! pharmasalmanac.com/r250-trip/day-…

Awesome strategy session with our $HTBX Biothreat Advisory Board. Looking forward to many more-

San Antonio, here we come! sanantonioreport.org/heat-biologics…

Our gp96 platform, which is designed to drive T-cells to fight #COVID19 and more, has been dosed in over 300 patients in several Heat-sponsored oncology trials, with a positive safety profile thus far in the clinic.

@JeremyHutchis14 @realDonaldTrump Thanks, Jeremy! Really appreciate it-

@JetsfanEZ Thanks, EZ! Appreciate your support!

@jeffwolfheatbio I still believe in you Jeff. Winners don't crumble under pressure. You got this.

Nice milestone today! More data emerging from labs around the world showing the importance of T-cells in protecting against COVID-19. That's where we come in! Look forward to updating you on our progress-

Despite what some say, American innovation, drive and chutzpah continues to lead the world. Congratulations to innovators like @elonmusk, and to our brave @SpaceX astronauts for their amazing success!

We have recently begun enrolling patients in a Phase 1 #ClinicalTrial with a new #oncology candidate. PTX-35 is an antibody that targets an entirely novel receptor involved in the immune response to #cancer. Learn more about the trial here: bit.ly/2VmX0kS

Congratulations to @moderna_tx on encouraging Phase 1 results for their #COVID19 vaccine. Our T-cell activating vaccine may be highly synergistic with their antibody-generating vaccine to provide an extra layer of T-cell protection for high-risk patients that need it most.

We are happy to announce significant progress on our #COVID19 efforts and anticipated milestones for our vaccine. Read more about our progress here: bit.ly/3fcxHKr

I’m pleased to announce that @HeatBiologics and @univmiami were added to the @WHO’s list of potential #vaccine candidates for #coronavirus. We will work hard to try to develop a vaccine for people affected by #COVID19 worldwide. See the list here: bit.ly/3d5OwWz